BNP PARIBAS FINANCIAL MARKETS - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 140 filers reported holding MERSANA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$156,648
-35.7%
123,345
+66.7%
0.00%
Q2 2023$243,467
-73.3%
74,002
-66.6%
0.00%
-100.0%
Q1 2023$911,220
+26.8%
221,708
+80.7%
0.00%0.0%
Q4 2022$718,881
-100.0%
122,676
-48.4%
0.00%
-66.7%
Q3 2022$1,606,615,000
-35.6%
237,665
-56.0%
0.00%
-25.0%
Q2 2022$2,493,428,000
-4.2%
539,703
-17.3%
0.00%0.0%
Q1 2022$2,603,926,000
-32.3%
652,613
+5.5%
0.00%
-20.0%
Q4 2021$3,846,548,000
+468.3%
618,416
+761.5%
0.01%
+400.0%
Q3 2021$676,885,000
+1893.8%
71,780
+2771.2%
0.00%
Q2 2021$33,950,000
-69.8%
2,500
-64.0%
0.00%
Q1 2021$112,386,000
-35.7%
6,946
+5.8%
0.00%
Q4 2020$174,774,000
-26.2%
6,568
-48.4%
0.00%
Q3 2020$236,809,000
+159.4%
12,718
+225.9%
0.00%
Q2 2020$91,307,000
+40.8%
3,902
-64.9%
0.00%
Q1 2020$64,830,000
+30.8%
11,120
+28.6%
0.00%
Q4 2019$49,553,000
+877.4%
8,648
+169.5%
0.00%
Q3 2019$5,070,000
-60.1%
3,209
+2.2%
0.00%
Q2 2019$12,717,000
-9.6%
3,140
+17.4%
0.00%
Q1 2019$14,065,000
+1117.7%
2,674
+844.9%
0.00%
Q4 2018$1,155,000
-75.6%
283
-40.2%
0.00%
Q3 2018$4,730,000
-44.0%
4730.0%0.00%
Q2 2018$8,448,000
-75.4%
473
-78.3%
0.00%
Q1 2018$34,347,000
+96.7%
2,178
+104.9%
0.00%
Q4 2017$17,465,0001,0630.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 5,000,000$6,350,0001.92%
VR Adviser, LLC 11,328,000$14,386,5601.51%
Bain Capital Life Sciences Investors, LLC 8,663,673$11,002,8651.23%
Affinity Asset Advisors, LLC 2,850,000$3,619,5001.02%
EcoR1 Capital, LLC 19,364,688$24,593,1540.83%
Altium Capital Management LP 1,059,136$1,345,1030.70%
5AM Venture Management, LLC 1,305,000$1,657,3500.48%
Decheng Capital Management III (Cayman), LLC 904,268$1,148,4200.38%
COMMODORE CAPITAL LP 2,244,378$2,850,3600.33%
Philosophy Capital Management LLC 2,342,634$2,975,1450.32%
View complete list of MERSANA THERAPEUTICS INC shareholders